120 related articles for article (PubMed ID: 8633026)
1. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns.
Sekido Y; Bader S; Latif F; Chen JY; Duh FM; Wei MH; Albanesi JP; Lee CC; Lerman MI; Minna JD
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4120-5. PubMed ID: 8633026
[TBL] [Abstract][Full Text] [Related]
2. RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies.
Kashuba VI; Li J; Wang F; Senchenko VN; Protopopov A; Malyukova A; Kutsenko AS; Kadyrova E; Zabarovska VI; Muravenko OV; Zelenin AV; Kisselev LL; Kuzmin I; Minna JD; Winberg G; Ernberg I; Braga E; Lerman MI; Klein G; Zabarovsky ER
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4906-11. PubMed ID: 15051889
[TBL] [Abstract][Full Text] [Related]
3. The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment.
Rolny C; Capparuccia L; Casazza A; Mazzone M; Vallario A; Cignetti A; Medico E; Carmeliet P; Comoglio PM; Tamagnone L
J Exp Med; 2008 May; 205(5):1155-71. PubMed ID: 18458115
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive review of tumor proliferative and suppressive role of semaphorins and therapeutic approaches.
Ahammad I
Biophys Rev; 2020 Oct; 12(5):1233-1247. PubMed ID: 32577918
[TBL] [Abstract][Full Text] [Related]
5. The role of semaphorin 3A on chondrogenic differentiation.
Tsuboi E; Asakawa Y; Hirose N; Yanoshita M; Sumi C; Takano M; Onishi A; Nishiyama S; Kubo N; Kita D; Tanimoto K
In Vitro Cell Dev Biol Anim; 2024 May; ():. PubMed ID: 38727898
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and Immune Implications of a Novel Pyroptosis-Related Five-Gene Signature in Breast Cancer.
Zheng Y; Wang K; Li N; Zhang Q; Chen F; Li M
Front Surg; 2022; 9():837848. PubMed ID: 35656090
[TBL] [Abstract][Full Text] [Related]
7. The Hippo pathway mediates Semaphorin signaling.
Meng Z; Li FL; Fang C; Yeoman B; Qiu Y; Wang Y; Cai X; Lin KC; Yang D; Luo M; Fu V; Ma X; Diao Y; Giancotti FG; Ren B; Engler AJ; Guan KL
Sci Adv; 2022 May; 8(21):eabl9806. PubMed ID: 35613278
[TBL] [Abstract][Full Text] [Related]
8. New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis.
Larionova I; Kazakova E; Gerashchenko T; Kzhyshkowska J
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209679
[TBL] [Abstract][Full Text] [Related]
9. SH3BP4 promotes neuropilin-1 and α5-integrin endocytosis and is inhibited by Akt.
Burckhardt CJ; Minna JD; Danuser G
Dev Cell; 2021 Apr; 56(8):1164-1181.e12. PubMed ID: 33761321
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of serum semaphorin 3B is associated with poor prognosis of patients with hepatocellular carcinoma.
Li GZ; Shen D; Li GH; Wei M; Zheng LJ; Liu ZL; Sun RQ; Zhou SJ; Zhang ZL; Gao YC
Exp Ther Med; 2021 Mar; 21(3):236. PubMed ID: 33603844
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of Semaphorin 3F as an alternative candidate to anti-VEGF monoclonal antibody on angiogenesis.
Tan G
In Vitro Cell Dev Biol Anim; 2019 Oct; 55(9):756-765. PubMed ID: 31420803
[TBL] [Abstract][Full Text] [Related]
12. Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression.
Toledano S; Nir-Zvi I; Engelman R; Kessler O; Neufeld G
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696103
[No Abstract] [Full Text] [Related]
13. Expression of circulating Semaphorin3A and its association with inflammation and bone destruction in rheumatoid arthritis.
Gao H; Ma XX; Guo Q; Xie LF; Zhong YC; Zhang XW
Clin Rheumatol; 2018 Aug; 37(8):2073-2080. PubMed ID: 29656374
[TBL] [Abstract][Full Text] [Related]
14. The crucial role of SEMA3F in suppressing the progression of oral squamous cell carcinoma.
Liu Y; Li R; Yin K; Ren G; Zhang Y
Cell Mol Biol Lett; 2017; 22():32. PubMed ID: 29299034
[TBL] [Abstract][Full Text] [Related]
15. GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.
Shahi P; Wang CY; Chou J; Hagerling C; Gonzalez Velozo H; Ruderisch A; Yu Y; Lai MD; Werb Z
Oncogene; 2017 Oct; 36(40):5567-5575. PubMed ID: 28581515
[TBL] [Abstract][Full Text] [Related]
16. Semaphorins and their Signaling Mechanisms.
Alto LT; Terman JR
Methods Mol Biol; 2017; 1493():1-25. PubMed ID: 27787839
[TBL] [Abstract][Full Text] [Related]
17. The role of the semaphorins in cancer.
Neufeld G; Mumblat Y; Smolkin T; Toledano S; Nir-Zvi I; Ziv K; Kessler O
Cell Adh Migr; 2016 Nov; 10(6):652-674. PubMed ID: 27533782
[TBL] [Abstract][Full Text] [Related]
18. The axon guidance molecule semaphorin 3F is a negative regulator of tumor progression and proliferation in ileal neuroendocrine tumors.
Bollard J; Massoma P; Vercherat C; Blanc M; Lepinasse F; Gadot N; Couderc C; Poncet G; Walter T; Joly MO; Hervieu V; Scoazec JY; Roche C
Oncotarget; 2015 Nov; 6(34):36731-45. PubMed ID: 26447612
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of class-3 semaphorins and their neuropilin receptors in oncology.
Nasarre P; Gemmill RM; Drabkin HA
Onco Targets Ther; 2014; 7():1663-87. PubMed ID: 25285016
[TBL] [Abstract][Full Text] [Related]
20. Lymphangiogenesis and metastasis--a closer look at the neuropilin/semaphorin3 axis.
Migliozzi MT; Mucka P; Bielenberg DR
Microvasc Res; 2014 Nov; 96():68-76. PubMed ID: 25087623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
